Gene · 51441
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition with Quizartinib and Milademetan in FLT3-ITD Mutant/TP53 Wild-type Acute Myeloid Leukemias. | Clin Cancer Res | 2025 | 40327322 | PubTator, text mining | PubMed |
| Silencing METTL3 and YTHDF2 increases HSP70 expression and promotes corneal epithelial healing. | Exp Eye Res | 2025 | 40324710 | PubTator, text mining | PubMed |
| SENP3 induced HADHA deSUMOylation enhances intrahepatic cholangiocarcinoma chemotherapy sensitivity via fatty acid oxidation. | Cancer Lett | 2025 | 40320039 | PubTator, text mining | PubMed |
| MSC-derived exosomes alleviate oxidative stress-induced lysosomal membrane permeabilization damage in degenerated nucleus pulposus cells via promoting m6A demethylation of Nrf2. | Free Radic Biol Med | 2025 | 40316061 | PubTator, text mining | PubMed |
| CRM1 mediates the nuclear export of YTHDF2. | Biochem Biophys Res Commun | 2025 | 40315567 | PubTator, text mining | PubMed |
| TNF-α inhibites non-small cell lung cancer cells proliferation by targeting THRIL in an FTO-YTHDF2-dependent manner. | Arch Biochem Biophys | 2025 | 40311994 | PubTator, text mining | PubMed |
| METTL3 Inhibition Restores PD-L1 Expression and CD8+ T-cell Cytotoxic Function in Immunotherapy-Treated Gastric Cancer. | Cancer Immunol Res | 2025 | 40299705 | PubTator, text mining | PubMed |
| Predictive models and WTAP targeting for idiopathic pulmonary fibrosis (IPF). | Sci Rep | 2025 | 40287490 | PubTator, text mining | PubMed |
| Fusion of glioma-associated mesenchymal stem/stromal cells with glioma cells promotes macrophage recruitment and M2 polarization via m6A modification of CSF1. | Cell Death Dis | 2025 | 40287444 | PubTator, text mining | PubMed |
| Biomolecules Interacting with Long Noncoding RNAs. | Biology (Basel) | 2025 | 40282307 | PubTator, text mining | PubMed |
| Pathological α-synuclein dysregulates epitranscriptomic writer METTL3 to drive neuroinflammation in microglia. | Cell Rep | 2025 | 40279247 | PubTator, text mining | PubMed |
| Enhancement of YTHDF2 plays a protective role in acute IRI models through downregulation of TUG1 expression. | PLoS One | 2025 | 40273066 | PubTator, text mining | PubMed |
| Hepatitis B Virus Promotes Angiogenesis in Hepatocellular Carcinoma by Increasing m6A Modification of VEGFA mRNA via IGF2BP3. | J Med Virol | 2025 | 40260505 | PubTator, text mining | PubMed |
| Lysozyme (LYZ) promotes PEDV replication via degrading m6A methylation of RIG-I transcripts through YTHDF2. | Int J Biol Macromol | 2025 | 40253018 | PubTator, text mining | PubMed |
| METTL3 orchestrates cancer progression by m6A-dependent modulation of oncogenic lncRNAs. | Int J Biol Macromol | 2025 | 40253016 | PubTator, text mining | PubMed |
| Epigenetics of maternal-fetal interface immune microenvironment and placental related pregnancy complications. | Front Immunol | 2025 | 40248704 | PubTator, text mining | PubMed |
| The m6A reader YTHDF2 protects vascular smooth muscle cells against the osteogenic differentiation through targeting Runx2. | Ren Fail | 2025 | 40230077 | PubTator, text mining | PubMed |
| Deciphering single-cell landscape unravels cell-type-specific functional roles of RNA m6A modification in atherosclerosis. | Theranostics | 2025 | 40225569 | PubTator, text mining | PubMed |
| N6-methyladenosine binding protein YTHDF2 inhibits gastric cancer cell growth and predicts better prognosis in patients with gastric cancer. | Transl Oncol | 2025 | 40215678 | PubTator, text mining | PubMed |
| Helicobacter pylori promotes YTHDF2-mediated SRA1 m 6 A modification and promotes the occurrence and development of gastric cancer. | Eur J Gastroenterol Hepatol | 2025 | 40207488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51441/papers?page=16